BioSpace News Archive

Three cardiac surgeons at Cleveland Clinic, Hackensack Meridian Health and Cedars-Sinai Medical Center are the first in the United States to implant Abiomed’s newest heart pump, the Impella 5.5 with SmartAssist. Ed Soltesz, MD, Mark Anderson, MD, and Danny Ramzy, MD, have each successfully implanted multiple pumps during cardiac procedures at their hospitals..

Nephros, Inc. (Nasdaq: NEPH), a commercial stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced that it will file its third quarter 2019 financial results on Wednesday, November 6, 2019

NexImmune, a clinical stage immunotherapy company developing novel T cell therapies, received Investigational New Drug (IND) clearance for the company’s first cellular therapy product

Intensity Therapeutics, Inc. announced that the first patient has been dosed with a combination of INT230-6, the Company’s lead investigational product, and Keytruda®, Merck’s anti-PD-1 therapy.

Unique product platform combines antibacterial capabilities within a high-performance hemostat

Zogenix, Inc., a global pharmaceutical company developing rare disease therapies, announced that it will report its financial results for the three and nine months ended September 30, 2019, after the market close, and will host a corporate update conference call and webcast on Thursday, November 7, 2019, at 4:30 PM Eastern Time.

Fulcrum Therapeutics, Inc. announced that it will host a key opinion leader breakfast symposium focused on understanding Facioscapulohumeral Dystrophy genetics, biology, and clinical implications, on Thursday, November 7, 2019 from 8:30 a.m. to 10:30 a.m. ET in New York, NY.

Predictive Technology Group, Inc., a leader in the development of genetic and molecular diagnostics and companion therapeutics, announced that it has engaged with LifeSci Partners to increase awareness of the company’s brand and clinical programs.

Geron Corporation (Nasdaq: GERN) today announced that it will release its third quarter 2019 financial results after the market closes on Wednesday, November 6, 2019 via press release, which will be available on the Company’s website at www.geron.com/investors

Catalyst Pharmaceuticals, Inc. announced that it will release third quarter 2019 financial result after market close on Tuesday, November 12, 2019.